Chemoreduction for retinoblastoma. Analysis of tumor control and risks for recurrence in 457 tumors
- 30 September 2004
- journal article
- clinical trial
- Published by Elsevier BV in American Journal of Ophthalmology
- Vol. 138 (3), 329-337
- https://doi.org/10.1016/j.ajo.2004.04.032
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- New retinoblastoma tumor formation in children initially treated with systemic carboplatinOphthalmology, 2003
- DiscussionOphthalmology, 2003
- Chemothermotherapy in the management of retinoblastomaOphthalmology, 2002
- Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleationAmerican Journal of Ophthalmology, 2002
- Chemotherapy for retinoblastomaMedical and Pediatric Oncology, 2002
- Multiagent chemotherapy as neoadjuvant treatment for multifocal intraocular retinoblastomaOphthalmology, 2001
- Chemotherapy Plus Local Treatment in the Management of Intraocular RetinoblastomaAmerican Journal of Ophthalmology, 1996
- Results of Combined Chemotherapy and Radiotherapy for Advanced Intraocular RetinoblastomaAmerican Journal of Ophthalmology, 1996
- Chemoreduction in the Initial Management of Intraocular RetinoblastomaAmerican Journal of Ophthalmology, 1996
- Chemotherapy With Focal Therapy Can Cure Intraocular Retinoblastoma Without RadiotherapyAmerican Journal of Ophthalmology, 1996